157 related articles for article (PubMed ID: 26456599)
1. Compendium of FAM46C gene mutations in plasma cell dyscrasias.
Barbieri M; Manzoni M; Fabris S; Ciceri G; Todoerti K; Simeon V; Musto P; Cortelezzi A; Baldini L; Neri A; Lionetti M
Br J Haematol; 2016 Aug; 174(4):642-5. PubMed ID: 26456599
[No Abstract] [Full Text] [Related]
2. A compendium of DIS3 mutations and associated transcriptional signatures in plasma cell dyscrasias.
Lionetti M; Barbieri M; Todoerti K; Agnelli L; Fabris S; Tonon G; Segalla S; Cifola I; Pinatel E; Tassone P; Musto P; Baldini L; Neri A
Oncotarget; 2015 Sep; 6(28):26129-41. PubMed ID: 26305418
[TBL] [Abstract][Full Text] [Related]
3. Biological and prognostic impact of APOBEC-induced mutations in the spectrum of plasma cell dyscrasias and multiple myeloma cell lines.
Maura F; Petljak M; Lionetti M; Cifola I; Liang W; Pinatel E; Alexandrov LB; Fullam A; Martincorena I; Dawson KJ; Angelopoulos N; Samur MK; Szalat R; Zamora J; Tarpey P; Davies H; Corradini P; Anderson KC; Minvielle S; Neri A; Avet-Loiseau H; Keats J; Campbell PJ; Munshi NC; Bolli N
Leukemia; 2018 Apr; 32(4):1044-1048. PubMed ID: 29209044
[No Abstract] [Full Text] [Related]
4. Mutational landscape reflects the biological continuum of plasma cell dyscrasias.
Rossi A; Voigtlaender M; Janjetovic S; Thiele B; Alawi M; März M; Brandt A; Hansen T; Radloff J; Schön G; Hegenbart U; Schönland S; Langer C; Bokemeyer C; Binder M
Blood Cancer J; 2017 Feb; 7(2):e537. PubMed ID: 28234344
[TBL] [Abstract][Full Text] [Related]
5. Molecular spectrum of TP53 mutations in plasma cell dyscrasias by next generation sequencing: an Italian cohort study and overview of the literature.
Lionetti M; Barbieri M; Manzoni M; Fabris S; Bandini C; Todoerti K; Nozza F; Rossi D; Musto P; Baldini L; Neri A
Oncotarget; 2016 Apr; 7(16):21353-61. PubMed ID: 26870891
[TBL] [Abstract][Full Text] [Related]
6. Molecular spectrum of BRAF, NRAS and KRAS gene mutations in plasma cell dyscrasias: implication for MEK-ERK pathway activation.
Lionetti M; Barbieri M; Todoerti K; Agnelli L; Marzorati S; Fabris S; Ciceri G; Galletti S; Milesi G; Manzoni M; Mazzoni M; Greco A; Tonon G; Musto P; Baldini L; Neri A
Oncotarget; 2015 Sep; 6(27):24205-17. PubMed ID: 26090869
[TBL] [Abstract][Full Text] [Related]
7. N- and K-ras oncogenes in plasma cell dyscrasias.
Corradini P; Ladetto M; Inghirami G; Boccadoro M; Pileri A
Leuk Lymphoma; 1994 Sep; 15(1-2):17-20. PubMed ID: 7858496
[TBL] [Abstract][Full Text] [Related]
8. Loss of
Zhu YX; Shi CX; Bruins LA; Jedlowski P; Wang X; Kortüm KM; Luo M; Ahmann JM; Braggio E; Stewart AK
Cancer Res; 2017 Aug; 77(16):4317-4327. PubMed ID: 28619709
[No Abstract] [Full Text] [Related]
9. Next-generation sequencing of a family with a high penetrance of monoclonal gammopathies for the identification of candidate risk alleles.
Bolli N; Barcella M; Salvi E; D'Avila F; Vendramin A; De Philippis C; Munshi NC; Avet-Loiseau H; Campbell PJ; Mussetti A; Carniti C; Maura F; Barlassina C; Corradini P; Montefusco V
Cancer; 2017 Oct; 123(19):3701-3708. PubMed ID: 28542843
[TBL] [Abstract][Full Text] [Related]
10. The non-canonical poly(A) polymerase FAM46C acts as an onco-suppressor in multiple myeloma.
Mroczek S; Chlebowska J; Kuliński TM; Gewartowska O; Gruchota J; Cysewski D; Liudkovska V; Borsuk E; Nowis D; Dziembowski A
Nat Commun; 2017 Sep; 8(1):619. PubMed ID: 28931820
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of tumor suppressor genes, p53 and Rb1, in plasma cell dyscrasias.
Corradini P; Inghirami G; Astolfi M; Ladetto M; Voena C; Ballerini P; Gu W; Nilsson K; Knowles DM; Boccadoro M
Leukemia; 1994 May; 8(5):758-67. PubMed ID: 8182933
[TBL] [Abstract][Full Text] [Related]
12. RAS mutations are uncommon in multiple myeloma and other monoclonal gammopathies.
Martín P; Santón A; García-Cosío M; Bellas C
Int J Oncol; 2005 Oct; 27(4):1023-8. PubMed ID: 16142319
[TBL] [Abstract][Full Text] [Related]
13. The role of miRNAs in plasma cell dyscrasias.
Glavey S; Manier S; Sacco A; Rossi G; Ghobrial IM; Roccaro AM
Microrna; 2014; 2(3):165-73. PubMed ID: 25069440
[TBL] [Abstract][Full Text] [Related]
14. RAS gene mutations in multiple myeloma and related monoclonal gammopathies.
Matozaki S; Nakagawa T; Nakao Y; Fujita T
Kobe J Med Sci; 1991 Feb; 37(1):35-45. PubMed ID: 1921261
[TBL] [Abstract][Full Text] [Related]
15. [Lymphoid malignancies: progress in diagnosis and treatment. Topics: I. Pathogenesis and pathophysiology--recent findings; 3. Etiology and pathogenesis of plasma cell dyscrasia including multiple myeloma].
Hattori Y
Nihon Naika Gakkai Zasshi; 2011 Jul; 100(7):1773-80. PubMed ID: 21863752
[No Abstract] [Full Text] [Related]
16. Structural and functional characterization of multiple myeloma associated cytoplasmic poly(A) polymerase FAM46C.
Zhang H; Zhang SH; Hu JL; Wu YT; Ma XY; Chen Y; Yu B; Liao S; Huang H; Gao S
Cancer Commun (Lond); 2021 Jul; 41(7):615-630. PubMed ID: 34048638
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal analysis of 25 sequential sample-pairs using a custom multiple myeloma mutation sequencing panel (M(3)P).
Kortüm KM; Langer C; Monge J; Bruins L; Zhu YX; Shi CX; Jedlowski P; Egan JB; Ojha J; Bullinger L; Kull M; Ahmann G; Rasche L; Knop S; Fonseca R; Einsele H; Stewart AK; Braggio E
Ann Hematol; 2015 Jul; 94(7):1205-11. PubMed ID: 25743686
[TBL] [Abstract][Full Text] [Related]
18. Circulating tumor DNA as a liquid biopsy in plasma cell dyscrasias.
Gerber B; Manzoni M; Spina V; Bruscaggin A; Lionetti M; Fabris S; Barbieri M; Ciceri G; Pompa A; Forestieri G; Lerch E; Servida P; Bertoni F; Zucca E; Ghielmini M; Cortelezzi A; Cavalli F; Stussi G; Baldini L; Rossi D; Neri A
Haematologica; 2018 Jun; 103(6):e245-e248. PubMed ID: 29472358
[No Abstract] [Full Text] [Related]
19. Analysis of chromosome 12p deletion in plasma cell dyscrasias.
Jiang N; Qi C; Yu L; Ning Y; An G; Qiu L; Chang H
Leuk Res; 2012 Jan; 36(1):32-6. PubMed ID: 21982640
[TBL] [Abstract][Full Text] [Related]
20. Immunologic basis for the rare occurrence of true nonsecretory plasma cell dyscrasias.
Decourt C; Galea HR; Sirac C; Cogné M
J Leukoc Biol; 2004 Sep; 76(3):528-36. PubMed ID: 15155772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
